Retinal vascular occlusions

• Type of Material: Article
• Authors: Ingrid U Scott, Penn State College of Medicine; Peter A Campochiaro, Johns Hopkins School of Medicine, Baltimore; Nancy Newman, Emory University; Valerie Biousse, Emory University
• Language: English
• Date: 2020-12-12
• Publisher: ELSEVIER SCIENCE INC
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2020 Elsevier Ltd. All rights reserved.
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1016/S0140-6736(20)31559-2
• Title of Journal or Parent Work: LANCET
• Volume: 396
• Issue: 10266
• Start Page: 1927
• End Page: 1940
• Keywords: CENTRAL VEIN OCCLUSION; MACULAR EDEMA SECONDARY; ENDOTHELIAL GROWTH-FACTOR; Science & Technology; Life Sciences & Biomedicine; General & Internal Medicine; Medicine, General & Internal; LOCAL INTRAARTERIAL FIBRINOLYSIS; LONG-TERM OUTCOMES; VISION LOSS; RISK-FACTORS; INTRAVENOUS THROMBOLYSIS; ARTERY-OCCLUSION; TRANSIENT ISCHEMIC ATTACK

Abstract

Acute retinal vascular occlusions are common causes of visual impairment. Although both retinal artery occlusions and retinal vein occlusions are associated with increased age and cardiovascular risk factors, their pathophysiology, systemic implications, and management differ substantially. Acute management of retinal artery occlusions involves a multidisciplinary approach including neurologists with stroke expertise, whereas treatment of retinal vein occlusions is provided by ophthalmologists. Optimisation of systemic risk factors by patients’ primary care providers is an important component of the management of these two disorders.